Diagnosing C. difficile infection early allows patients to be discharged earlier, frees up bed space and reduces costs.
- Clostridium difficile (C. difficile), the major cause of hospital-acquired diarrhoea, is highly infectious and can spread rapidly in healthcare facilities if not identified and contained quickly.
- Up to 25% of antibiotic-associated diarrhoea is caused by C. difficile infection¹. Outbreaks are common, with significant fatality rates (=20%)² and huge cost implications.
- C. difficile infection needs to be efficiently diagnosed to reduce patient readmission rates which can cost healthcare systems over $17 bn annually³
Benefits of HG C. difficile:
- Simple protocol with = 4 minutes hands-on time – traditional methods comprise highly complex procedures
- Results in = 60 minutes – enables timely treatment and isolation procedures – conventional culture methods can take up to 72 hours
- One test to specifically identify individuals infected with toxigenic (A & B) strains – negates the need for complex testing algorithms
|Methodology:||Loop Mediated Isothermal Amplification (LAMP)|
|Target:||Toxigenic strains (A&B) of Clostridium difficile|
|Sample types:||Unformed stool|
|Hands-on time:||= 4 minutes|
|Sample to result:||= 60 minutes|
|Product Name||# of Tests||Catalogue|
|HG C. Difficile||30||HGCDIFFR|
|HG C. Difficile Control||18||HGCDIFFC|
|HG Swift Plus||–||HG SWIFT PLUS STARTPCK|
*FDA submission is planned. Product is not available for sale in the US market.
- J. Bartlett et al. Clinical recognition and diagnosis of Clostridium difficile infection, 2008
- J. Pépin et al. Mortality attributable to nosocomial Clostridium difficile–associated disease during an epidemic caused by a hypervirulent strain in Quebec, 2005
- Howard K., Preventing 30 Day Readmissions of Clostridium difficile Patients Utilizing Targeted Discharge Instructions, 2015